losartan has been researched along with Carcinoma, Lobular in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Carcinoma, Lobular: A type of BREAST CANCER where the abnormal malignant cells form in the lobules, or milk-producing glands, of the breast.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Navarro Suay, R | 1 |
| de Tena Gómez, MD | 1 |
| García Aroca, MÁ | 1 |
| López Soberón, E | 1 |
1 other study available for losartan and Carcinoma, Lobular
| Article | Year |
|---|---|
[Intraoperative anaphylaxis due to beta-lactams in a hypertensive patient on angiotensin ii receptor antagonists and beta-blockers].
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Anaphylaxis; Angiotensin II Type 1 Receptor Blockers; | 2015 |